Search Results

There are 186248 results for: content related to: Xeomin ® use in patients with systemic immune reactions to other botulinum toxins type A

  1. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE)

    Intervention Review

    The Cochrane Library

    Brian J Hoare, Margaret A Wallen, Christine Imms, Elmer Villanueva, Hyam Barry Rawicki and Leeanne Carey

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD003469.pub4

  2. Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity

    European Journal of Neurology

    Volume 19, Issue 5, May 2012, Pages: 725–732, A. Conte, A. Giannantoni, S. Proietti, S. Giovannozzi, G. Fabbrini, A. Rossi, M. Porena and A. Berardelli

    Version of Record online : 28 DEC 2011, DOI: 10.1111/j.1468-1331.2011.03618.x

  3. You have free access to this content
    Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis

    International Journal of Urology

    Volume 21, Issue S1, April 2014, Pages: 49–55, Jia-Fong Jhang, Yuan-Hong Jiang and Hann-Chorng Kuo

    Version of Record online : 7 MAY 2014, DOI: 10.1111/iju.12317

  4. You have free access to this content
    Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review

    Developmental Medicine & Child Neurology

    Volume 55, Issue 4, April 2013, Pages: 304–313, TAMIS W PIN, JESSICA ELMASRY and JENNY LEWIS

    Version of Record online : 24 OCT 2012, DOI: 10.1111/j.1469-8749.2012.04438.x

  5. You have full text access to this OnlineOpen article
    Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A

    The Journal of Physiology

    Volume 586, Issue 13, July 2008, Pages: 3163–3182, A. A. Rogozhin, K. K. Pang, E. Bukharaeva, C. Young and C. R. Slater

    Version of Record online : 28 JUN 2008, DOI: 10.1113/jphysiol.2008.153569

  6. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement

    European Journal of Neurology

    Volume 17, Issue s2, August 2010, Pages: 9–37, S. C. Love, I. Novak, M. Kentish, K. Desloovere, F. Heinen, G. Molenaers, S. O’Flaherty and H. K. Graham

    Version of Record online : 15 JUL 2010, DOI: 10.1111/j.1468-1331.2010.03126.x

  7. You have free access to this content
    Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers

    Cellular Microbiology

    Volume 10, Issue 2, February 2008, Pages: 375–387, Aurélie Couesnon, Yannick Pereira and Michel R. Popoff

    Version of Record online : 17 SEP 2007, DOI: 10.1111/j.1462-5822.2007.01051.x

  8. You have free access to this content
    Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A

    The Journal of Physiology

    Volume 591, Issue 4, February 2013, Pages: 1017–1029, Véronique Marchand-Pauvert, Claire Aymard, Louis-Solal Giboin, Federica Dominici, Alessandro Rossi and Riccardo Mazzocchio

    Version of Record online : 2 NOV 2012, DOI: 10.1113/jphysiol.2012.239178

  9. You have free access to this content
    Traffic of Botulinum Toxins A and E in Excitatory and Inhibitory Neurons

    Traffic

    Volume 8, Issue 2, February 2007, Pages: 142–153, Claudia Verderio, Carlotta Grumelli, Luca Raiteri, Silvia Coco, Silvio Paluzzi, Paola Caccin, Ornella Rossetto, Giambattista Bonanno, Cesare Montecucco and Michela Matteoli

    Version of Record online : 28 NOV 2006, DOI: 10.1111/j.1600-0854.2006.00520.x

  10. You have full text access to this OnlineOpen article
    Translocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epithelia

    Cellular Microbiology

    Volume 17, Issue 8, August 2015, Pages: 1133–1143, Tina I. Lam, Larry H. Stanker, Kwangkook Lee, Rongsheng Jin and Luisa W. Cheng

    Version of Record online : 15 FEB 2015, DOI: 10.1111/cmi.12424

  11. You have free access to this content
    Modulation of botulinum neurotoxin A catalytic domain stability by tyrosine phosphorylation

    FEBS Letters

    Volume 578, Issue 1-2, December 03, 2004, Pages: 121–127, Cristina Ibañez, Clara Blanes-Mira, Gregorio Fernández-Ballester, Rosa Planells-Cases and Antonio Ferrer-Montiel

    Version of Record online : 11 NOV 2004, DOI: 10.1016/j.febslet.2004.10.084

  12. Acute and chronic effects of botulinum neurotoxin a on the mammalian neuromuscular junction

    Muscle & Nerve

    Volume 50, Issue 2, August 2014, Pages: 206–215, Padmamalini Baskaran and Baskaran Thyagarajan

    Version of Record online : 9 MAY 2014, DOI: 10.1002/mus.24119

  13. Advances in the use of botulinum neurotoxins in facial esthetics

    Journal of Cosmetic Dermatology

    Volume 11, Issue 1, March 2012, Pages: 42–50, Timothy Corcoran Flynn

    Version of Record online : 24 FEB 2012, DOI: 10.1111/j.1473-2165.2011.00593.x

  14. You have free access to this content
    Persistence of botulinum neurotoxin action in cultured spinal cord cells 1,2

    FEBS Letters

    Volume 456, Issue 1, July 30, 1999, Pages: 137–142, James E Keller, Elaine A Neale, George Oyler and Michael Adler

    Version of Record online : 28 JUL 1999, DOI: 10.1016/S0014-5793(99)00948-5

  15. You have free access to this content
    Differential entry of botulinum neurotoxin A into neuronal and intestinal cells

    Cellular Microbiology

    Volume 11, Issue 2, February 2009, Pages: 289–308, Aurélie Couesnon, Takeshi Shimizu and Michel R. Popoff

    Version of Record online : 31 OCT 2008, DOI: 10.1111/j.1462-5822.2008.01253.x

  16. Early botulinum toxin treatment for spastic pes equinovarus – a randomized double-blind placebo-controlled study

    European Journal of Neurology

    Volume 21, Issue 8, August 2014, Pages: 1089–1095, U. M. Fietzek, P. Kossmehl, L. Schelosky, G. Ebersbach and J. Wissel

    Version of Record online : 12 FEB 2014, DOI: 10.1111/ene.12381

  17. Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview

    Journal of the European Academy of Dermatology and Venereology

    Volume 24, Issue s1, January 2010, Pages: 1–14, B Rzany, B Ascher and GD Monheit

    Version of Record online : 20 NOV 2009, DOI: 10.1111/j.1468-3083.2009.03475.x

  18. Understanding peptide competitive inhibition of botulinum neurotoxin a binding to SV2 protein via molecular dynamics simulations

    Biopolymers

    Volume 103, Issue 10, October 2015, Pages: 597–608, Shan Chang, Hong-Qiu He, Lin Shen and Hua Wan

    Version of Record online : 24 JUL 2015, DOI: 10.1002/bip.22682

  19. You have free access to this content
    Botulinum toxin injection for lower urinary tract dysfunction

    International Journal of Urology

    Volume 20, Issue 1, January 2013, Pages: 40–55, Yue-Chen Kuo and Hann-Chorng Kuo

    Version of Record online : 9 MAY 2012, DOI: 10.1111/j.1442-2042.2012.03035.x

  20. Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease

    Movement Disorders

    Volume 26, Issue 2, 1 February 2011, Pages: 313–319, Arianna Guidubaldi, Alfonso Fasano, Tamara Ialongo, Carla Piano, Maurizio Pompili, Roberta Mascianà, Luisa Siciliani, Mario Sabatelli and Anna Rita Bentivoglio

    Version of Record online : 21 JAN 2011, DOI: 10.1002/mds.23473